Skip to content
naulon
Not checkedNot checked for notices yet.

Medical Cannabis Induced Acute Pancreatitis and Hyperemesis Syndrome in a Patient with Complex Regional Pain Syndrome

Cheryl Hutflesz, Vikas Parihar

Canadian Journal of Pain · 2019

doi:10.1080/24740527.2019.1592390 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Introduction: Medical cannabis is being utilized for intractable pain that is not well managed through conventional means. There are reports of cannabis induced hyperemesis syndrome and acute pancreatitis amongst recreational users inhaling cannabis, but not amongst medical users consuming cannabis orally. Patient Case: A 33-year old male with complex regional pain syndrome initiated 1 g of medical cannabis per day consisting of CBD (25 mg/mL) and tetrahydrocannabinol (<2 mg/mL). He transitioned to a balanced 50:50 CBD to THC product 12.5 mg/mL of each every six hours. He achieved good pain and anxiety relief but developed gastrointestinal cramping, bloating, intermittent nausea and vomiting which he managed with homeopathic remedies. He added THC only at bedtime and symptoms exacerbated over 3 months. He experienced worsening abdominal pain, nausea, projectile vomiting and weight loss. He was found to have epigastric and right and left upper quadrant abdominal tenderness as well as elevated lipase >300. Abdominal ultrasound and CT abdomen with contrast were negative. Serial lipase levels rose to >800. He stopped all cannabis products. Oral Haldol 0.5mg QID was initiated for hyperemesis after ondansetron failure. After 1 week CBD dominant oil was reintroduced at 1ml (25mg) QID for CRPS with no worsening of GI symptoms. After 2.5 weeks off THC hyperemesis dramatically improved, weight loss stabilized and lipase returned to baseline. Conclusion: Chronic oral administration of medical cannabis containing tetrahydrocannabinol resulted in acute pancreatitis and hyperemesis similar to individuals inhaling recreational cannabis. Patients and healthcare providers should be counselled on the rare but serious complications of medical cannabis induced pancreatitis.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.